SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-10-001021
Filing Date
2010-08-31
Accepted
2010-08-31 14:36:19
Documents
9
Period of Report
2010-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k.htm 6-K 14966
2 ANNUAL FINANCIAL STATEMENTS ex991.htm EX-99.1 1002732
3 MANAGEMENT DISCUSSION AND ANALYSIS ex992.htm EX-99.2 369421
4 ANNUAL INFORMATION FORM ex993.htm EX-9.3 420195
5 CEO/CFO CERTIFICATION ex994.htm EX-99.4 47652
6 LOGO logo.jpg GRAPHIC 16727
7 GRAPHIC graph1.jpg GRAPHIC 133417
8 GRAPHIC kpmg.jpg GRAPHIC 3900
9 GRAPHIC kpmgsig.jpg GRAPHIC 5208
  Complete submission text file 0001279569-10-001021.txt   2076623
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 101049733
SIC: 2836 Biological Products, (No Diagnostic Substances)